-$229.5M
Net Activity
Institutions Holding
239
Popularity Rank
#2482
Avg Weight
0.14%
Total Value
$985.5M
239 institutions currently hold PCRX, with 112 net buyers and 130 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
130
Net Buying Institutions
112
Top 5 by Value
+$370.2M
Total Buy Value
$640.1M
Total Sell Value
112
Net Buyers
130
Net Sellers
3
Filings (90d)
$583K
Total Est. Value
25K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Ceesay Abraham | 2026-06-12 | $210K |
| RIKER LAUREN | 2026-06-11 | $144K |
| WILLIAMS KRISTEN | 2026-06-04 | $228K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Pacira BioSciences has agreed to sell its subsidiary Pacira CryoTech and its handheld cryoanalgesia devices (including iovera®) to Zimmer Biomet's subsidiary for up to $140 million, including $70 million upfront and up to $70 million in milestones based on future revenue. The deal is expected to close in the third quarter of 2026. About 66 employees, representing 8% of Pacira's workforce, are expected to be hired by the buyer.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter